Ignite Creation Date:
2024-05-06 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03597282
Status:
TERMINATED
Last Update Posted:
2020-09-03
First Post:
2018-07-13
Brief Title:
A Personal Cancer Vaccine NEO-PV-01 and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
Sponsor:
BioNTech US Inc
Organization:
BioNTech SE
Organization Data
Organization:
BioNTech SE
Class:
INDUSTRY
Study ID:
NT-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioNTech US Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Apexigen America Inc | INDUSTRY |